Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 10/20 | 0.34 |
| ▸ | CREBBP | Q92793 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.32 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.32 |
| ▸ | AXL | P30530 | 1/20 | 0.31 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.31 |
| ▸ | MERTK | Q12866 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31489182 | 0.76 | PDK2 (0.36) | PDK2CREBBP | |
| SCHEMBL31489229 | 0.76 | PDK2 (0.36) | PDK2CREBBP | |
| SCHEMBL31489235 | 0.76 | CCNE2 (0.33) | KDM4ESMN1; SMN2 | |
| SCHEMBL31489637 | 0.74 | MKNK1 (0.39) | KDM4ESMN1; SMN2 | |
| SCHEMBL31489553 | 0.74 | CYP11B2 (0.40) | KDM4ESMN1; SMN2 | |
| SCHEMBL31489816 | 0.74 | CYP11B2 (0.40) | KDM4ESMN1; SMN2 | |
| SCHEMBL31489493 | 0.73 | CREBBP (0.32) | CREBBP | |
| SCHEMBL31489550 | 0.72 | CYP26A1 (0.30) | — | |
| SCHEMBL31489410 | 0.72 | CYP26A1 (0.30) | — | |
| SCHEMBL31489649 | 0.72 | CYP26A1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072395-A1 | TRIAZOLOPYRIDINYL COMPOUNDS AS KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-04-03 | — | — | WO | disclosed |